Firefly Aerospace Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers events occurring between August 6, 2025, and August 8, 2025. Firefly Aerospace Inc. (the "Company") completed its Initial Public Offering (IPO) and entered into several material definitive agreements in connection with the offering. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Capital Structure
Initial Public Offering (IPO):
- Shares Sold: 19,296,000 Firm Shares plus 2,894,400 Option Shares (fully exercised).
- Public Offering Price: $45.00 per share.
- Underwriter Purchase Price: $42.4125 per share.
- Closing Date: August 8, 2025.
- Underwriters: Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, Jefferies LLC, and Wells Fargo Securities, LLC.
New Credit Facility:
- Facility Type: Senior secured revolving credit facility.
- Aggregate Principal Amount: $125.0 million.
- Maturity Date: August 8, 2028.
- Sublimits: $15.0 million for letters of credit; $7.5 million for swingline loans.
- Interest Rate: Term SOFR + 3.00% or Alternative Base Rate + 2.00%.
- Commitment Fee: 0.375% per annum on unused commitments.
Consulting Agreement:
- Counterparty: AE Industrial Operating Partners, LLC (affiliate of a principal stockholder).
- Annual Fee: Approximately $2.4 million.
- Term: Until August 8, 2027, or earlier if the affiliate's ownership drops below 10%.
Material Changes and Covenants
The Company terminated its previous Second Amended and Restated Financing Agreement dated May 20, 2024, upon entering the new Credit Agreement. The new facility imposes specific financial covenants:
- Liquidity Covenant: Minimum liquidity of $50.0 million (tested quarterly starting Q4 2025).
- Free Cash Flow Covenant: Minimum free cash flow of negative $325.0 million (tested quarterly starting Q4 2025).
- Leverage Covenant Trigger: Upon achieving positive consolidated EBITDA, the liquidity and cash flow covenants are replaced by a maximum first lien net leverage ratio of 4.00:1.00.
The Credit Agreement includes customary negative covenants restricting additional debt, liens, asset sales, dividends, and mergers.
Guidance, Outlook, and Governance Changes
Board and Governance:
- Four new directors were appointed on August 8, 2025: Pamela Braden, Kevin McAllister, Jon Lusczakoski, and Ryan Boland.
- The Company adopted an Amended and Restated Certificate of Incorporation and Bylaws effective August 8, 2025.
- Indemnification agreements were executed with all directors and executive officers.
Equity Incentives:
- Adopted the 2025 Omnibus Incentive Plan and the 2025 Employee Stock Purchase Plan (ESPP).
Registration Rights:
- A Registration Rights Agreement was entered into, granting Sponsor Investors unlimited demand registration rights and Astera Institute specific demand rights (two Long-Form, unlimited Short-Form) subject to minimum offering values.
Outlook and Risks:
The filing does not provide specific revenue guidance or profit outlook beyond the structural changes to the capital base. Key risks include compliance with the new financial covenants, specifically the liquidity and free cash flow thresholds, and the potential dilution from future demand registrations by significant stockholders.
Investor Verification Checklist
- Verify the total gross proceeds from the IPO by calculating the share count (22,190,400) against the public offering price ($45.00) and deducting underwriting discounts.
- Review the full text of the Credit Agreement (Exhibit 10.1) to understand specific definitions of "Free Cash Flow" and "EBITDA" used in the covenants.
- Confirm the current liquidity position of the Company to ensure compliance with the $50.0 million minimum liquidity covenant effective December 31, 2025.
- Examine the Registration Rights Agreement (Exhibit 10.2) to assess potential future dilution from Sponsor Investors and Astera Institute.
- Review the Prospectus for details on the use of proceeds from the IPO and the specific terms of the Director Nomination Agreement.